Reports
Sale
Global Molecular Diagnostics Market Share, Size, Trends, Forecast: By Technology: Polymerase Chain Reaction (PCR), Hybridisation, DNA Sequencing, Microarray, Others; By Application: Infectious diseases, Oncology, Genetic Testing, Blood Screening, Others; By Type; By End User; Regional Analysis; SWOT Analysis; Competitive Landscape; 2018-2028
Global Molecular Diagnostics Market Outlook
The global molecular diagnostics market size reached a value of more than USD 35.8 billion in 2022. The market growth is aided by the favourable schemes and funding services provided by the government and increasing collaborative efforts taken by the market players.
Global Molecular Diagnostics Market Trends
Molecular diagnostics, also known by the term molecular pathology, is a technique used for the detection of genomic variants, diagnosis, and prognosis, facilitating detection, and monitoring patient response to treatment. In this procedure, the DNA and RNA are taken to analyse and detect any caution point that indicates the potential emergence of a specific disease.
- The rising prevalence of contagious diseases and growing cases of cancer are the major factors driving the market growth for molecular diagnostics. As such cases increase in prevalence, healthcare providers are more focused on providing better diagnostic and treatment solutions to the patients, which can propel the market demand for molecular diagnostics.
- Increased funding provided through government initiatives, programs, or funding activities to new and established market players for research and development is expected to aid the proliferation of the market value. With the increased funding, market players will be enabled to bring innovation and development to the molecular diagnostics market.
- The rising awareness among people for early diagnosis and acceptance of personalised medication can drive market growth. The demand for molecular diagnosis surged in recent years due to the COVID-19 pandemic.
- The rising geriatric population around the world can enhance the development of the market as they are more susceptible to getting infected, leading to an increased number of cases. With the increased prevalence of diseases among the ageing population, hospitals and healthcare institutes are expected to provide better diagnostic services, which can augment the market growth.
Global Molecular Diagnostics Market Analysis
Based on technology, the market can be segmented into polymerase chain reaction (PCR), hybridisation, DNA sequencing, microarray, and isothermal nucleic acid amplification technology (INAAT), among others. Based on application, it can be bifurcated into infectious diseases, oncology, genetic testing, and blood screening, among others.
Based on type, the market can be divided into instruments, reagents, software and services. Based on end-user, the market can be categorised into hospital and reference laboratories, among others. The regional markets for molecular diagnostics) the market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global molecular diagnostics market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments and expansion plans.
- BioMérieux SA.
- Becton, Dickinson and Company
- Hologic Inc.
- QIAGEN
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche Ltd.
- Others
Key Technologies in the Market for Molecular Diagnostics
Based on technology, the market bifurcations include polymerase chain reaction (PCR), hybridisation, DNA sequencing, microarray, and isothermal nucleic acid amplification technology (INAAT), among others.
Among these segments, polymerase chain reaction (PCR) is expected to cover a significant portion of the market. This can be attributed to the technologies cost-effectiveness and quick turnaround time. It is one of the most widely used technologies for diagnostics and the development of portable real-time PCR machines can further enhance the market value.
Different Areas of Application for Molecular Diagnostics
Based on application, the molecular diagnostics market can be categorised into different sections including infectious diseases, oncology, genetic testing, and blood screening, among others.
The infectious disease segment is expected to dominate the market owing to the rising prevalence of different such diseases. The outbreak of infectious diseases. such as H1N1 and COVID-19, has increased the awareness for early diagnosis among people, which has propelled the demand for molecular diagnosis. The outbreak also increased the importance of effective diagnosis for disease detection, which has propelled the market players to increase their investment in research and development, further aiding the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
BioMérieux SA is a leading multinational biotechnology company, established in Marcy-l'Étoile, France. The company was founded in 1963 and currently, it is present in 44 countries and provides its service to more than 160 countries. They have engaged in collaborative partnerships to develop innovative solutions to fight against infectious diseases. One of the company’s aims is to pioneer, develop, and produce high-quality in vitro diagnostics that can aid in improving public health worldwide.
Beckton, Dickson and Company, commonly known as BD, is a multinational American company that specialises in manufacturing and distributing medical devices for the improvement of both clinical therapy for patients and clinical processes conducted by healthcare providers. It has become one of the largest medical technology companies in the world after operating in the field since 1897. The company specialises in the fields of medical devices, biosciences, medical supplies, reagents, diagnostic products, antibodies, surgical, and vascular access.
Hologic Inc. is headquartered in Massachusetts, United States.h The company has been operating in the field of medical technology to enable healthier lives around the world. The company was founded in 1985 and has specialised in various fields including breast and skeletal health, diagnostic, GYN surgical solutions, and medical aesthetics.
Other players in the market include QIAGEN, Siemens Healthcare GmbH, and F. Hoffmann-La Roche Ltd., among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Region
7 Opportunities and Challenges in the Market
8 Global Molecular Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Global Molecular Diagnostics Historical Market (2018-2022)
8.3 Global Molecular Diagnostics Market Forecast (2023-2028)
8.4 Global Molecular Diagnostics Market by Technology
8.4.1 Polymerase Chain Reaction (PCR)
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Hybridisation
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 DNA Sequencing
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Microarray
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2022)
8.4.5.3 Forecast Trend (2023-2028)
8.4.6 Others
8.5 Global Molecular Diagnostics Market by Application
8.5.1 Infectious diseases
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Oncology
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Genetic Testing
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Blood Screening
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Molecular Diagnostics Market by Type
8.6.1 Instruments
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Reagents
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Software and Services
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.7 Global Molecular Diagnostics Market by End User
8.7.1 Hospital
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Reference Laboratories
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Others
8.8 Global Molecular Diagnostics Market by Region
8.8.1 North America
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2018-2022)
8.8.1.3 Forecast Trend (2023-2028)
8.8.2 Europe
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2018-2022)
8.8.2.3 Forecast Trend (2023-2028)
8.8.3 Asia Pacific
8.8.3.1 Market Share
8.8.3.2 Historical Trend (2018-2022)
8.8.3.3 Forecast Trend (2023-2028)
8.8.4 Latin America
8.8.4.1 Market Share
8.8.4.2 Historical Trend (2018-2022)
8.8.4.3 Forecast Trend (2023-2028)
8.8.5 Middle East and Africa
8.8.5.1 Market Share
8.8.5.2 Historical Trend (2018-2022)
8.8.5.3 Forecast Trend (2023-2028)
9 North America Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 BioMérieux SA.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Becton, Dickinson and Company
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Hologic Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 QIAGEN
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Siemens Healthcare GmbH
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 F. Hoffmann-La Roche Ltd.
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Molecular Diagnostics Market: Key Industry Highlights, 2018 and 2028
2. Global Molecular Diagnostics Historical Market: Breakup by Technology (USD Billion), 2018-2022
3. Global Molecular Diagnostics Market Forecast: Breakup by Technology (USD Billion), 2023-2028
4. Global Molecular Diagnostics Historical Market: Breakup by Application (USD Billion), 2018-2022
5. Global Molecular Diagnostics Market Forecast: Breakup by Application (USD Billion), 2023-2028
6. Global Molecular Diagnostics Historical Market: Breakup by Type (USD Billion), 2018-2022
7. Global Molecular Diagnostics Market Forecast: Breakup by Type (USD Billion), 2023-2028
8. Global Molecular Diagnostics Historical Market: Breakup by End-User (USD Billion), 2018-2022
9. Global Molecular Diagnostics Market Forecast: Breakup by End-User (USD Billion), 2023-2028
10. Global Molecular Diagnostics Historical Market: Breakup by Region (USD Billion), 2018-2022
11. Global Molecular Diagnostics Market Forecast: Breakup by Region (USD Billion), 2023-2028
12. North America Molecular Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2022
13. North America Molecular Diagnostics Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Europe Molecular Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Europe Molecular Diagnostics Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Asia Pacific Molecular Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Asia Pacific Molecular Diagnostics Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Latin America Molecular Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Latin America Molecular Diagnostics Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Middle East and Africa Molecular Diagnostics Historical Market: Breakup by Country (USD Billion), 2018-2022
21. Middle East and Africa Molecular Diagnostics Market Forecast: Breakup by Country (USD Billion), 2023-2028
22. Global Molecular Diagnostics Market Structure.
Key Questions Answered in the Report
The global market for molecular diagnostics reached a size of USD 35.8 billion in 2022.
The market growth is driven by the rising prevalence of contagious diseases, which has led to a rise in the number of cases in hospitals and healthcare centres and increasing innovation and developments in diagnostic procedures.
The increasing funding provided by favourable schemes and programs offered by the government and collaborations and partnerships between key players for research and development of innovative solutions is expected to deliver new growth opportunities to the market.
The regional markets for the market include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
The technologies available in the market include polymerase chain reaction (PCR), hybridisation, DNA sequencing, microarray, and isothermal nucleic acid amplification technology (INAAT), among others.
There are multiple applications of molecular diagnostics, including infectious diseases, oncology, genetic testing, and blood screening, among others.
The different types of molecular diagnostics found in the market are instruments, reagents, and software and services.
Molecular diagnostics are used by hospitals and reference laboratories, among others.
The key players in the market include BioMérieux SA., Becton, Dickinson and Company, Hologic Inc., QIAGEN, Siemens Healthcare GmbH, and F. Hoffmann-La Roche Ltd, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$4199$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER